4//SEC Filing
Schalop Lee Troy 4
Accession 0001641172-25-025000
CIK 0001763950other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 6:25 PM ET
Size
5.6 KB
Accession
0001641172-25-025000
Insider Transaction Report
Form 4
Schalop Lee Troy
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-08-19+5,000→ 5,000 totalExercise: $4.46Exp: 2035-08-18→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Equity Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing September 19, 2025.
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0002072339
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 6:25 PM ET
- Size
- 5.6 KB